# Maxi Nicotine

NDC: 11822-3317
Generic name: nicotine polacrilex
Labeler / Manufacturer: Rite Aid Corporation
Product type: HUMAN OTC DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: LOZENGE
Routes: ORAL
Marketing started: 20191129
Marketing ended: 20261129
FDA application: ANDA209206

## Active ingredients

- NICOTINE: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11822-3317"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11822-3317
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1472b0a3-5ff1-44e7-8748-a3b1a5e55196